Chemoinformaics analysis of 5,9-DIMETHYL-2-DECANONE
| Molecular Weight | 184.323 | nRot | 7 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 1 |
| Exact Molecular Weight | 184.183 | nRing | 0 |
| Solubility: LogS | -4.161 | nHRing | 0 |
| Solubility: LogP | 3.974 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 36.845 |
| nHD | 0 | BPOL | 24.945 |
| QED | 0.588 |
| Synth | 2.571 |
| Natural Product Likeliness | 1.225 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.337 |
| MDCK | 0.0000198 |
| BBB | 0.96 |
| PPB | 0.950357 |
| VDSS | 1.072 |
| FU | 0.037756 |
| CYP1A2-inh | 0.722 |
| CYP1A2-sub | 0.704 |
| CYP2c19-inh | 0.384 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.604 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.246 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.18 |
| CL | 7.907 |
| T12 | 0.493 |
| hERG | 0.022 |
| Ames | 0.004 |
| ROA | 0.018 |
| SkinSen | 0.544 |
| Carcinogencity | 0.063 |
| EI | 0.971 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.547967 |